Physician profile
Allison Tracy
NPI 1467013979
$7,375.58
in general payments reported to CMS, 2019-2025
10 companies · $4,681 in 2025
The $4,681 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $67.12 · 2024: $2,628 · 2025: $4,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,800 · Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,800.00 |
| Food and Beverage | $575.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $6,817.54 | 2024-2025 | Bovine Collagen |
| Astellas Pharma US INC | $221.33 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $118.01 | 2023-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $79.96 | 2024 | |
| Ethicon US, LLC | $38.08 | 2024 | Dermabond Prineo, Vistaseal, Stratafix |
| Daiichi Sankyo INC. | $29.88 | 2024 | Injectafer |
| Hologic Sales and Service, LLC | $22.61 | 2025 | Novasure |
| Pfizer INC. | $17.28 | 2025 | |
| Millicent US INC | $16.09 | 2025 | Femlyv |
| Minerva Surgical, INC | $14.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.